Sugi Predict

Sugi Predict / Compounds / SCHEMBL667630

SCHEMBL667630

SCHEMBL667630

COC(=O)CC(C)(C)CC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.50
▸ HSD17B10 Q99714 3/20 0.46
▸ MGAM O43451 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ SI P14410 2/20 0.46
▸ MGAM2 Q2M2H8 2/20 0.46
▸ TET2 Q6N021 1/20 0.42
▸ CA12 O43570 4/20 0.41
▸ CA14 Q9ULX7 4/20 0.41
▸ RECQL P46063 2/20 0.41
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ CA7 P43166 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ CA2 P00918 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 1/20 0.34
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL162441 0.90 KDM4E (0.48) TSHRHSD17B10MGAMGAASI
SCHEMBL11026137 0.90 MGAM (0.50) TSHRHSD17B10MGAMGAASI
SCHEMBL5856664 0.88 TSHR (0.40) TSHRHSD17B10MGAMGAASI
Hydrochloric Acid SCHEMBL7900820 0.88 KDM4E (0.52) TSHRHSD17B10MGAMGAASI
SCHEMBL12055303 0.88 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL2526094 0.88 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL130707 0.87 TSHR (0.43) TSHRHSD17B10MGAMGAASI
SCHEMBL7256439 0.87 TSHR (0.43) TSHRHSD17B10MGAMGAASI
SCHEMBL13908769 0.86 TSHR (0.39) TSHRHSD17B10MGAMGAASI
SCHEMBL9226097 0.85 TSHR (0.50) TSHRHSD17B10MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115710538-B Self-emulsifying cleaning material and preparation method and application thereof 国网上海市电力公司 2024-01-19 — — CN claimed
CN-115710538-A Self-emulsifying cleaning material and preparation method and application thereof 国网上海市电力公司 2023-02-24 — — CN claimed
EP-3796900-B1 TRITERPENE AMINE DERIVATIVES DFH THERAPEUTICS (US) 2026-04-08 — — EP disclosed
CN-115710538-B Self-emulsifying cleaning material and preparation method and application thereof 国网上海市电力公司 2024-01-19 — — CN disclosed
CN-115710538-A Self-emulsifying cleaning material and preparation method and application thereof 国网上海市电力公司 2023-02-24 — — CN disclosed
US-20220356148-A1 ANTIVIRAL COMPOUNDS HAPLOGEN GMBH (AT) 2022-11-10 — — US disclosed
CN-109689649-B Bicyclic heteroaryl substituted compounds 百时美施贵宝公司 2022-07-19 — — CN disclosed
US-11236122-B2 Triterpene amine derivatives DFH THERAPEUTICS (US) 2022-02-01 — — US disclosed
US-20210253627-A1 TRITERPENE AMINE DERIVATIVES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2021-08-19 — — US disclosed
US-11091428-B2 Antiviral compounds HAPLOGEN GMBH (AT) 2021-08-17 — — US disclosed
US-11091428-B2 Antiviral compounds HAPLOGEN GMBH (AT) 2021-08-17 — — US disclosed
US-9505800-B2 Extended triterpene derivatives MYREXIS, INC. (US) 2016-11-29 — — US disclosed
US-20120046291-A1 Extended Triterpene Derivatives MYREXIS, INC. 2012-02-23 — — US disclosed
WO-2008057420-A2 EXTENDED TRITERPENE DERIVATIVES PANACOS PHARMACEUTICALS, INC. (US) 2008-05-15 — — WO disclosed
US-RE37078-E1 Thiophene compounds ADIR ET COMPAGNIE (FR) 2001-02-27 — — US disclosed
US-5705525-A ANTIINFLAMMATORY AGENTS AND TREATMENT OF RHEUMATIC DISEASES ADIR ET COMPAGNIE (FR) 1998-01-06 — — US disclosed
US-5034296-A Photoconductive imaging members with fluorene polyester hole transporting layers XEROX CORPORATION (US) 1991-07-23 — — US disclosed
EP-0065706-B1 PROCESS FOR THE PREPARATION OF 3,3-DIMETHYLGLUTARIC ACID OR ITS ESTERS LONZA AG (CH) 1985-01-16 — — EP disclosed
US-4433163-A Process for the production of 3,3-dimethylglutaric acid or its esters LONZA LTD. (CH) 1984-02-21 — — US disclosed
EP-0065706-A1 Process for the preparation of 3,3-dimethylglutaric acid or its esters LONZA AG (CH) 1982-12-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253627-A1 TRITERPENE AMINE DERIVATIVES BET1, PGGT1B, NFATC1 TSHR 4117/4885HSD17B10 2411/4885MGAM 4605/4885
US-20220356148-A1 ANTIVIRAL COMPOUNDS PLA2G12A, PLA2G1B, PLA2G4C TSHR 4240/4885HSD17B10 2290/4885MGAM 2622/4885
US-20120046291-A1 Extended Triterpene Derivatives BET1, PGGT1B, TMPO TSHR 4604/4885HSD17B10 1104/4885MGAM 3484/4885
US-11091428-B2 Antiviral compounds PLA2G1B, PLA2G12A, PLA2G4C TSHR 4378/4885HSD17B10 2146/4885MGAM 2742/4885
US-11236122-B2 Triterpene amine derivatives BET1, PGGT1B, NFATC1 TSHR 4117/4885HSD17B10 2411/4885MGAM 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.